allurion technologies inc - ALUR

ALUR

Close Chg Chg %
1.37 0.04 2.56%

Closed Market

1.40

+0.04 (2.56%)

Volume: 28.14K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: allurion technologies inc - ALUR

ALUR Key Data

Open

$1.38

Day Range

1.36 - 1.40

52 Week Range

1.03 - 16.13

Market Cap

$12.78M

Shares Outstanding

9.26M

Public Float

8.10M

Beta

-0.45

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$6.67

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

101.93K

 

ALUR Performance

1 Week
 
-5.44%
 
1 Month
 
-9.74%
 
3 Months
 
-33.49%
 
1 Year
 
-87.21%
 
5 Years
 
N/A
 

ALUR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About allurion technologies inc - ALUR

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.

ALUR At a Glance

Allurion Technologies, Inc.
11 Huron Drive
Natick, Massachusetts 01760
Phone 1-508-647-4000 Revenue 32.11M
Industry Medical Specialties Net Income -7,198,000.00
Sector Health Technology Employees 137
Fiscal Year-end 12 / 2025
View SEC Filings

ALUR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.752
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.032
Enterprise Value to Sales 1.454
Total Debt to Enterprise Value 0.812

ALUR Efficiency

Revenue/Employee 234,379.562
Income Per Employee -52,540.146
Receivables Turnover 4.501
Total Asset Turnover 0.614

ALUR Liquidity

Current Ratio 1.44
Quick Ratio 1.259
Cash Ratio 0.815

ALUR Profitability

Gross Margin 65.584
Operating Margin -144.021
Pretax Margin -20.181
Net Margin -22.417
Return on Assets -13.773
Return on Equity N/A
Return on Total Capital 17.97
Return on Invested Capital N/A

ALUR Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital -94.677
Total Debt to Total Assets 115.573
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital -92.508
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Allurion Technologies Inc - ALUR

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
- - 53.47M 32.11M
-
Sales Growth
- - - -39.94%
-
Cost of Goods Sold (COGS) incl D&A
- - 12.35M 11.05M
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 746.00K 997.00K
-
Depreciation
- - 746.00K 997.00K
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - -10.51%
-
Gross Income
- - 41.12M 21.06M
-
Gross Income Growth
- - - -48.78%
-
Gross Profit Margin
- - +76.90% +65.58%
-
2021 2022 2023 2024 5-year trend
SG&A Expense
2.03M 4.49M 120.20M 67.30M
Research & Development
- - 27.52M 17.13M
-
Other SG&A
2.03M 4.49M 92.68M 50.17M
SGA Growth
+44,445.20% +120.93% +2,578.36% -44.00%
Other Operating Expense
- - 200.05K 200.00K
-
Unusual Expense
(7.94M) (28.56M) (7.73M) (41.48M)
EBIT after Unusual Expense
5.71M 23.87M (71.34M) (4.77M)
Non Operating Income/Expense
49.77K 10.66M (643.00K) 552.00K
Non-Operating Interest Income
- 49.77K 10.66M 1.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 10.57M 2.26M
-
Interest Expense Growth
- - - -78.57%
-
Gross Interest Expense
- - 10.57M 2.26M
-
Interest Capitalized
- - - -
-
Pretax Income
5.76M 34.54M (82.55M) (6.48M)
Pretax Income Growth
+111,584.74% +499.31% -339.03% +92.15%
Pretax Margin
- - -154.40% -20.18%
-
Income Tax
- 2.17M 264.00K 718.00K
Income Tax - Current - Domestic
- - - 2.17M
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (1.70M)
-
Consolidated Net Income
5.76M 32.37M (84.51M) (7.20M)
Minority Interest Expense
- - - -
-
Net Income
5.76M 32.37M (84.51M) (7.20M)
Net Income Growth
+111,584.74% +461.74% -361.08% +91.48%
Net Margin Growth
- - -158.07% -22.42%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
5.76M 32.37M (84.51M) (7.20M)
Preferred Dividends
- - - -
-
Net Income Available to Common
5.76M 32.37M (84.51M) (7.20M)
EPS (Basic)
1.3362 7.8765 -59.38 -3.2032
EPS (Basic) Growth
+111,450.00% +489.47% -853.89% +94.61%
Basic Shares Outstanding
4.31M 4.11M 1.42M 2.25M
EPS (Diluted)
1.3362 7.8765 -59.38 -3.2032
EPS (Diluted) Growth
+111,450.00% +489.47% -853.89% +94.61%
Diluted Shares Outstanding
4.31M 4.11M 1.42M 2.25M
EBITDA
(2.23M) (4.69M) (78.33M) (45.25M)
EBITDA Growth
-43,058.80% -110.09% -1,571.02% +42.24%
EBITDA Margin
- - -146.51% -140.92%
-

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 5.50
Number of Ratings 2 Current Quarters Estimate -0.72
FY Report Date 12 / 2025 Current Year's Estimate -3.045
Last Quarter’s Earnings -1.53 Median PE on CY Estimate N/A
Year Ago Earnings -11.64 Next Fiscal Year Estimate -1.32
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 1 2 2
Mean Estimate -0.72 -0.50 -3.05 -1.32
High Estimates -0.63 -0.50 -2.15 -0.48
Low Estimate -0.81 -0.50 -3.94 -2.16
Coefficient of Variance -17.68 N/A -41.57 -90.00

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 2 2
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Allurion Technologies Inc - ALUR

Date Name Shares Transaction Value
Apr 18, 2025 RTW Investments LP Director 1,324,532 Conversion of derivative security Non-derivative transaction at $3.35 per share 4,437,182.20
Apr 18, 2025 RTW Investments LP Director 1,027,287 Conversion of derivative security Non-derivative transaction at $3.35 per share 3,441,411.45
Apr 18, 2025 RTW Investments LP Director 164,233 Conversion of derivative security Non-derivative transaction at $3.35 per share 550,180.55
Apr 18, 2025 RTW Investments LP Director N/A Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 18, 2025 RTW Investments LP Director N/A Conversion of derivative security 0.00
Apr 2, 2025 Shantanu K. Gaur Chief Executive Officer; Director 8,000 Open market or private purchase of non-derivative security Non-derivative transaction at $3.35 per share 26,800.00

Allurion Technologies Inc in the News